Sharh maqola

NTRK fusion-positive cancers and TRK inhibitor therapy

Emiliano CoccoHuman Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USAMaurizio ScaltritiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USAAlexander DrilonDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [email protected]

2018en

ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

DOI: 10.1038/s41571-018-0113-0

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar